CTLA4 and non-small cell lung carcinoma: In a study of patients with non-small cell lung cancer receiving PD-1 checkpoint blockade therapy, higher (vs. lower) expression of CTLA4 protein in the macrophage compartment assessed by the DSP assay was associated with worse survival [22].